Adrienne L. Melck, BSc MD MPH FRCSC

Clinical Associate Professor, Division of General Surgery

Active Staff: St. Paul’s Hospital

City: Vancouver
Hospital Authority: Vancouver Coastal Health

Rm. C303 – 1081 Burrard Street
St. Paul’s Hospital, Department of Surgery
Vancouver, BC V6Z 1Y6

Phone: 604.806.9108, extension 3   Fax: 604.568.6214

Area’s of Research & Clinical Interest

  • Endocrine Surgery


  1. Melck A, Armstrong M, Stang M, Carty S, Yip L.
    Medication discontinuation after curative surgery for sporadic primary hyperparathyroidism.
    Surgery, 148(6), Dec 2010: 1113-1118.
  2. Melck A, Yip L and Carty S.
    The Utility of BRAF Testing in the Management of Papillary Thyroid Cancer.
    The Oncologist, 15(12) Dec 2010: 1285-1293..
  3. Melck A, Yip L, Seethala R, Armstrong M, Stang M, Ogilvie J, Carty S.
    Recurrent Hyperparathyroidism and Forearm Parathyromatosis after Total Parathyroidectomy.
    Surgery, 148(4), Oct 2010: 873-875.
  4. Melck A, and Wiseman SM.
    Harmonic Scalpel Compared to Conventional Hemostasis in Thyroid Surgery: a Meta-analysis of Randomized Clinical Trials.
    Int J Surg Onc, Jan 2010:1-8.
  5. Melck A, Yip L.
    Predicting Malignancy in Thyroid Nodules: Molecular Advances.
    Head and Neck, In press, 2010
  6. Merchant S, Hameed M, Melck A.
    Pregnancy among Residents Enrolled in General Surgery (PREGS): a Survey of Residents in a Single Canadian Training Program.
    Can J Surg, Manuscript in press, 2010
  7. Melck A and Carty SE.
    Evaluation of a New Thyroid Nodule.
    In the Handbook of Endocrine Surgery. Sippel R, Editor. In press, 2010.
  8. Wiseman SM, Melck AMasoudi H, Ghaidi F, Goldstein L, Gown A, Jones SJM, Griffith OL.
    Molecular Phenotyping of Thyroid Tumors Identifies a Marker Panel for Differentiated Thyroid Cancer Diagnosis.
    Ann Surg Oncol, 15(10), Oct 2008: 2811-2826.
  9. Baliski C, Nosyk B, Melck ABugis S, Rosenberg F, Anis A.
    The Cost-effectiveness of Three Strategies for the Surgical Treatment of Symptomatic Primary Hyperparathyroidism.
    Ann Surg Oncol, 5(10), Oct 2008: 2653-2660.
  10. Griffith OL, Melck AJones SJM, Wiseman SM.
    Thyroid Cancer: Identification of Gene Expression Markers for Diagnosis. In Methods of Cancer Diagnosis, Therapy and Prognosis.
    Hayat MA, editor. Springer Publishing Company. New York, NY. Sept. 2008.
  11. Wiseman SM, Griffith OL, Melck AMasoudi H, Gown A, Nabi R, Jones SJM.
    Evaluation of Type 1 Growth Factor Receptor Family Expression in Benign and Malignant Thyroid Lesions.
    Am J Surg, 195(5), May 2008: 667-673.
  12. Shoman N, Melck AHolmes D, Irvine R, Bugis S, Zhang H, Wiseman SM.
    Utility of Intraoperative Parathyroid Hormone Measurement in Predicting Postparathyroidectomy Hypocalcemia.
    J Otolaryngol Head Neck Surg., 37(1), Feb 2008: 16-22.
  13. Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, Bugis S, Jones SJM, Wiseman SM.
    Cell Cycle Regulators show Diagnostic and Prognostic Utility for Differentiated Thyroid Cancer.
    Ann Surg Oncol, 14(12), Dec 2007: 3403-11.
  14. Melck A, Webber EM, Sidhu RS.
    Resident Continuity of Care Experience: A Casualty of Ambulatory Surgery and Current Patient Admission Practices.
    Am J Surg, 193(2), Feb 2007: 243-7.
  15. Griffith OL, Melck AJones SJ, Wiseman SM.
    Meta-analysis and Meta-review of Thyroid Cancer Gene Expression Profiling Studies Identifies Important Diagnostic Biomarkers.
    J Clin Oncol., 24(31), Nov 2006: 5043-51.
  16. Melck A, Bugis S, Baliski C, Irvine R, Anderson D, Wilkins G, Zhang H, Wiseman SM.
    Hemithyroidectomy: The Preferred Initial Surgical Approach for Management of Hurthle Cell Neoplasm.
    Am J Surg, 191(5), May 2006: 593-7.
  17. Gagnon J, Melck AKamal D, Al-Assiri M, Chen J, Sidhu RS.
    Continuity of Care Experience of Residents in an Academic Vascular Department: Are Trainees Learning Complete Surgical Care?
    J Vasc Surg., 43(5), May 2006: 999-1003.